<DOC>
	<DOC>NCT00168233</DOC>
	<brief_summary>To investigate the effect of treatment of HIV infection with highly active antiretroviral therapy on individual steps of reverse cholesterol transport, endothelial function and intima-media thickness in HIV patients.</brief_summary>
	<brief_title>Impact of HIV and Its Treatment on Reverse Cholesterol Transport</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Male patients with HIV infection (3 groups of 50 patients each) HIV infected patients, na誰ve to ARV therapy and not likely to need to commence therapy for the duration of followup (12 months) HIVinfected patients, PI na誰ve, initiating therapy with PIcontaining HAART (ARV na誰ve or NNRTI experienced changing to PI regimen) HIVinfected patients na誰ve to ARV therapy, initiating NNRTIcontaining regimen Exclusion criteria Treatment with any form of lipid lowering drugs, including fish oils. Body Mass Index greater than 27.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Treatment Naive</keyword>
	<keyword>HIV</keyword>
</DOC>